This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Toray Industries, Inc.. Active years: 2017-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Fuchu, JP (2017)
- Kurayoshi, JP (2018)
Company Filing History:
Years Active: 2017-2018
Title: Innovations by Yoshihisa Yamane
Introduction
Yoshihisa Yamane is a notable inventor based in Kurayoshi, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of uremia. With a total of 2 patents, his work focuses on improving the quality of life for patients suffering from chronic renal failure.
Latest Patents
Yamane's latest patents include a method of ameliorating uremia, which involves administering a therapeutic agent containing beraprost or its isomers to animals in the Family Canidae. This method ensures that the effective dosage does not significantly lower blood pressure. Another patent details a therapeutic agent and treatment method for uremia in both humans and animals. This agent is designed to be easily taken, have lower side effects, and be cost-effective. It comprises a prostaglandin I derivative, such as beraprost sodium, which alleviates symptoms of uremia without accompanying side effects.
Career Highlights
Yoshihisa Yamane is associated with Toray Industries, Inc., where he continues to innovate in the medical field. His work has been instrumental in developing treatments that improve the well-being of patients with chronic renal failure.
Collaborations
Yamane has collaborated with notable colleagues, including Masahiko Takenaka and Hajimu Kurumatani. Their combined expertise has contributed to the advancement of therapeutic methods in the field.
Conclusion
Yoshihisa Yamane's contributions to the treatment of uremia highlight his dedication to improving patient care. His innovative patents reflect a commitment to medical advancements that benefit both humans and animals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
